非酒精性脂肪性肝病与2型糖尿病患者心血管疾病及全因死亡的相关性:全国性人群研究
该全国性人群研究基于韩国2009年国家健康筛查项目的7 796 763名参与者,按NAFLD状态(无NAFLD:脂肪肝指数<30;1级NAFLD:30≤脂肪肝指数<60;2级NAFLD:脂肪肝指数≥60)分为三组,中位随访8.13年。2型糖尿病患者中1级NAFLD占34.06%、2级NAFLD占26.73%,均高于无2型糖尿病者(1级21.20%、2级10.02%)。心血管疾病和全因死亡的发病率及5年绝对风险随NAFLD等级升高而增加,且2型糖尿病患者高于无2型糖尿病者。结论认为,2型糖尿病患者的NAFLD似乎与心血管疾病和全因死亡风险升高相关,即使轻度NAFLD也是如此。
要点
- 2型糖尿病患者中1级NAFLD占34.06%、2级NAFLD占26.73%,均高于无2型糖尿病者(1级21.20%、2级10.02%)。
- 5年心血管疾病绝对风险:无NAFLD的2型糖尿病患者3.34(95%CI 3.27-3.41),1级NAFLD 3.94(3.87-4.02),2级NAFLD 4.66(4.54-4.78)。
- 5年全因死亡绝对风险:无NAFLD的2型糖尿病患者3.68(95%CI 3.61-3.74),1级NAFLD 4.25(4.18-4.33),2级NAFLD 5.91(5.78-6.05)。
- 无NAFLD的2型糖尿病患者5年心血管疾病和全因死亡绝对风险高于无2型糖尿病但伴2级NAFLD者。
- 无NAFLD与1级或2级NAFLD之间的心血管疾病和全因死亡风险差在2型糖尿病患者中大于无2型糖尿病者。
适用人群与场景
- 2009年韩国国家健康筛查项目的7 796 763名参与者,其中6.49%(n=505 763)患有2型糖尿病。
- 按NAFLD状态分为三组:无NAFLD(脂肪肝指数<30)、1级NAFLD(30≤脂肪肝指数<60)、2级NAFLD(脂肪肝指数≥60)。
- 中位随访8.13年。
诊断标准与关键阈值
- NAFLD分级依据脂肪肝指数:无NAFLD为脂肪肝指数<30;1级NAFLD为30≤脂肪肝指数<60;2级NAFLD为脂肪肝指数≥60。
研究设计与关键结果
- 研究类型:全国性人群研究(纵向队列研究),样本量7 796 763名参与者,中位随访8.13年。
- 2型糖尿病患者中1级NAFLD占34.06%、2级NAFLD占26.73%,无2型糖尿病者中1级NAFLD占21.20%、2级NAFLD占10.02%。
- 5年心血管疾病绝对风险(95%CI):无2型糖尿病者中,无NAFLD为1.03(1.02-1.04)、1级NAFLD为1.23(1.22-1.25)、2级NAFLD为1.42(1.40-1.45);2型糖尿病患者中,无NAFLD为3.34(3.27-3.41)、1级NAFLD为3.94(3.87-4.02)、2级NAFLD为4.66(4.54-4.78)。
- 5年全因死亡绝对风险(95%CI):无2型糖尿病者中,无NAFLD为1.25(1.24-1.26)、1级NAFLD为1.50(1.48-1.51)、2级NAFLD为2.09(2.06-2.12);2型糖尿病患者中,无NAFLD为3.68(3.61-3.74)、1级NAFLD为4.25(4.18-4.33)、2级NAFLD为5.91(5.78-6.05)。
- 无NAFLD的2型糖尿病患者5年心血管疾病和全因死亡绝对风险高于无2型糖尿病但伴2级NAFLD者。
- 无NAFLD与1级或2级NAFLD之间的心血管疾病和全因死亡风险差在2型糖尿病患者中大于无2型糖尿病者。
证据类型、等级与局限
- 证据类型:全国性人群研究(纵向队列研究)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文结论认为,2型糖尿病患者的NAFLD似乎与心血管疾病和全因死亡风险升高相关,即使轻度NAFLD也是如此;无NAFLD与1级或2级NAFLD之间的风险差在2型糖尿病患者中更大。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the risk of non-alcoholic fatty liver disease (NAFLD) for cardiovascular disease and all cause death in patients with type 2 diabetes mellitus (T2DM).
DESIGN: Nationwide population based study.
SETTING: Longitudinal cohort study in Korea.
PARTICIPANTS: 7 796 763 participants in the National Health Screening Programme in 2009 were divided into three groups based on NAFLD status: no NAFLD (fatty liver index<30); grade 1 NAFLD (30≤fatty liver index<60); and grade 2 NAFLD (fatty liver index≥60). Median follow-up was 8.13 years.
MAIN OUTCOME MEASURES: The primary outcome was incident cardiovascular disease (myocardial infarction, ischaemic stroke) or all cause death.
RESULTS: Of 7 796 763 participants, 6.49% (n=505 763) had T2DM. More patients with T2DM had grade 1 NAFLD (34.06%) and grade 2 NAFLD (26.73%) than those without T2DM (grade 1 NAFLD: 21.20%; grade 2 NAFLD: 10.02%). The incidence rate (per 1000 person years) of cardiovascular disease and all cause death increased in the order of no NAFLD, grade 1 NAFLD, and grade 2 NAFLD, and the incidence rates in patients with T2DM were higher than those in patients without T2DM. The five year absolute risk for cardiovascular disease and all cause death increased in the order of no NAFLD, grade 1 NAFLD, and grade 2 NAFLD in patients without and with T2DM (no NAFLD, without T2DM: 1.03, 95% confidence interval 1.02 to 1.04, and 1.25, 1.24 to 1.26, respectively; grade 1 NAFLD, without T2DM: 1.23, 1.22 to 1.25, and 1.50, 1.48 to 1.51, respectively; grade 2 NAFLD, without T2DM: 1.42, 1.40 to 1.45, and 2.09, 2.06 to 2.12, respectively; no NAFLD, with T2DM: 3.34, 3.27 to 3.41, and 3.68, 3.61 to 3.74, respectively; grade 1 NAFLD, with T2DM: 3.94, 3.87 to 4.02, and 4.25, 4.18 to 4.33, respectively; grade 2 NAFLD, with T2DM: 4.66, 4.54 to 4.78, and 5.91, 5.78 to 6.05, respectively). Patients with T2DM and without NAFLD had a higher five year absolute risk for cardiovascular disease and all cause death than those without T2DM and with grade 2 NAFLD. Risk differences for cardiovascular disease and all cause death between no NAFLD and grade 1 or grade 2 NAFLD were higher in patients with T2DM than in those without T2DM.
CONCLUSIONS: NAFLD in patients with T2DM seems to be associated with a higher risk of cardiovascular disease and all cause death, even in patients with mild NAFLD. Risk differences for cardiovascular disease and all cause death between the no NAFLD group and the grade 1 or grade 2 NAFLD groups were higher in patients with T2DM than in those without T2DM.
参考来源
- Kim KS, Hong S, Han K, et al. Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study. BMJ. 2024. PMID: 38350680. doi:10.1136/bmj-2023-076388
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。